Mesoblast rattles tin for at least $37m with Bell Potter

MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, is no… read more

14 new senior healthcare executives sought for key roles

MELBOURNE: Fourteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more

Brookfield set to buy back debt in Healthscope deal

MELBOURNE: Canadian private equity fund Brookfield is understood to have bought back about $250m worth… read more

Morgan Stanley tapping Rothschild for Healius group bid

MELBOURNE: Morgan Stanley Infrastructure Partners is understood to have tapped advisory firm Rothschild & Co… read more